Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: In vitro and in vivo evaluation
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference24 articles.
1. In vitro expansion of hematopoietic progenitors and maintenance of stem cells: comparison between Flt3/Flk2 ligand and kit ligand;Yonemura;Blood,2002
2. The roles of FLT3 in hematopoiesis and leukemia;Gilliland;Blood,2002
3. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of flt3 ligand;Haylock;Blood,1997
4. Dendritic cells in models of tumor immunity. Role of Flt3 ligand;Maliszewski;Pathol. Biol.,2001
5. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells;Park;Exp. Cell Res.,2009
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review;Heliyon;2024-08
2. Nano-TRAIL: a promising path to cancer therapy;Cancer Drug Resistance;2023
3. Role of Nano-immunotherapy in Colorectal Cancer: An Updated Review;Colon Cancer Diagnosis and Therapy Vol. 3;2022
4. Nanovesicles for colon-targeted drug delivery;Applications of Nanovesicular Drug Delivery;2022
5. The biomedical significance of multifunctional nanobiomaterials: The key components for site-specific delivery of therapeutics;Life Sciences;2021-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3